IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q2 2022 Holdings

Filed 2022-08-15 | 11 holdings | $146.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$131.1M643,00089.4%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$14.7M1,390,79010.0%
Alkermes PLC(ALKS)SHSG01767105$418.3K14,040,0000.3%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$189.0K16,390,0000.1%
Innoviva Inc(INVA)COM45781M101$97.6K6,614,0000.1%
Gilead Sciences Inc(GILD)COM375558103$82.9K1,341,9000.1%
Amarin Corp PLCSPONS ADR NEW023111206$35.8K23,998,0000.0%
Mersana Therapeutics IncCOM59045L106$19.9K4,299,2970.0%
VOR Biopharma IncCOM929033108$3.1K618,0000.0%
Pear Therapeutics IncCLASS A COM704723105$771500,3560.0%
Regulus Therapeutics Inc(RGLS)COM75915K309$383185,1830.0%